Artesunate-Pyronaridine Granules is a fixed-dose artemisinin-based combination antimalarial.
It combines artesunate (a fast-acting artemisinin derivative) and pyronaridine (a long-acting blood schizonticide), providing rapid clearance of parasites and preventing resistance.
Granule form is easy to take, especially for children and patients with swallowing difficulties.
Indications
For the treatment of acute uncomplicated malaria caused by Plasmodium falciparum (including chloroquine-resistant strains) in adults and children.
Key Features
Highly effective artemisinin combination therapy (ACT)
Rapid parasite clearance and high cure rate
Reduces risk of antimalarial drug resistance
Granule dosage form, convenient for pediatric use
Good safety and tolerability profile
Complies with WHO prequalification standards
Produced under strict GMP conditions
Complete registration dossiers available for malaria-endemic regions
Storage
Store in a cool, dry place, protected from light and moisture.
Keep out of reach of children.
